FILIP JANKU to Skin
This is a "connection" page, showing publications FILIP JANKU has written about Skin.
Connection Strength
0.032
-
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers. Invest New Drugs. 2021 06; 39(3):785-795.
Score: 0.032
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.